Galapagos NV reports results for the quarter ended June 30 - Earnings Summary

• Galapagos NV GLPG.AS reported a quarterly adjusted loss of €1.60​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 14 cents. The mean expectation of two analysts for the quarter was for a loss of 9 cents per share. Wall Street expected results to range from -41 cents to 23 cents per share.

• Revenue fell 16.2% to €65.29 million from a year ago; analysts expected €71.33 million.

• Galapagos NV's reported EPS for the quarter was a loss of €1.60​.

• The company reported a quarterly loss of €105.75 million.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 63.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

• Wall Street's median 12-month price target for Galapagos NV is €25.00, about 13.7% below its last closing price of €28.42

This summary was machine generated from LSEG data July 23 at 10:26 p.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)